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Ulrich S, Schneider SR, Bloch KE. Effect of hypoxia and hyperoxia on
exercise performance in healthy individuals and in patients with pulmonary hyper-
tension: a systematic review. J Appl Physiol 123: 1657–1670, 2017. First published
August 2, 2017; doi:10.1152/japplphysiol.00186.2017.—Exercise performance is
determined by oxygen supply to working muscles and vital organs. In healthy
individuals, exercise performance is limited in the hypoxic environment at altitude,
when oxygen delivery is diminished due to the reduced alveolar and arterial oxygen
partial pressures. In patients with pulmonary hypertension (PH), exercise perfor-
mance is already reduced near sea level due to impairments of the pulmonary
circulation and gas exchange, and, presumably, these limitations are more pro-
nounced at altitude. In studies performed near sea level in healthy subjects, as well
as in patients with PH, maximal performance during progressive ramp exercise and
endurance of submaximal constant-load exercise were substantially enhanced by
breathing oxygen-enriched air. Both in healthy individuals and in PH patients, these
improvements were mediated by a better arterial, muscular, and cerebral oxygen-
ation, along with a reduced sympathetic excitation, as suggested by the reduced
heart rate and alveolar ventilation at submaximal isoloads, and an improved
pulmonary gas exchange efficiency, especially in patients with PH. In summary, in
healthy individuals and in patients with PH, alterations in the inspiratory PO2 by
exposure to hypobaric hypoxia or normobaric hyperoxia reduce or enhance exercise
performance, respectively, by modifying oxygen delivery to the muscles and the
brain, by effects on cardiovascular and respiratory control, and by alterations in
pulmonary gas exchange. The understanding of these physiological mechanisms
helps in counselling individuals planning altitude or air travel and prescribing
oxygen therapy to patients with PH.
exercise; hyperoxia; hypoxia; pulmonary hypertension
INTRODUCTION
Exercise performance is determined by the oxygen supply to
working muscles and vital organs, including the brain (43).
Maximal exercise performance and oxygen uptake (V˙ O2) are
reduced in the hypoxic environment at altitude or with simu-
lated hypobaric or normobaric hypoxia (46, 63). On the other
hand, oxygen-enriched air [normobaric hyperoxia, increased
fraction of inspired oxygen (FIO2)] may enhance exercise per-
formance in healthy individuals and, potentially to an even
higher extent, in patients with respiratory diseases associated
with exercise-induced hypoxemia, such as pulmonary hyper-
tension (PH) (12). Thus studies on the effect of breathing
oxygen-enriched air near sea level on exercise performance in
healthy individuals and in patients with respiratory disease may
help to identify mechanisms involved in exercise limitation in
normoxia and in the hypoxic environment at altitude.
The purpose of the present work is, therefore, to review the
physiological effects of hypobaric or normobaric hypoxia and
of normobaric hyperoxia on exercise performance in healthy
subjects and in patients with PH as an example of a group of
cardiorespiratory diseases associated with impaired pulmonary
gas exchange and circulation. The mini-review is based on a
systematic analysis of the literature to identify potential ther-
apeutic targets and areas of future research.
EFFECT OF HYPOXIA ON EXERCISE PERFORMANCE IN
HEALTHY INDIVIDUALS
Exercise performance is determined by oxygen delivery to
the muscles by the cardiorespiratory system, the diffusion of
oxygen from the capillaries into the cells, and the utilization of
oxygen by the skeletal muscles (2). At higher exercise intensity,
the oxygen supply by the cardiorespiratory system may not meet
the metabolic demand, and accumulation of H and inorganic
phosphates at the neuromuscular junction and in the muscle cell
limit contractility and induce fatigue (1, 3). The simultaneously
increasingly inadequate oxygen delivery to the brain has been
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suggested to limit exercise by cessation of central command to the
locomotor system (4, 41, 44).
Exposure to hypobaric hypoxia at altitude challenges the
oxygen delivery system to organs at rest and even more during
exercise, when skeletal muscular oxygen demand substantially
increases. Acute exposure to high altitude induces an increase
in ventilation and heart rate, mainly driven by hypoxemia-
induced carotid chemoreceptor activation, sympathoexcitation,
and vagal withdrawal (Fig. 1) (38, 56). The heart rate-mediated
initial increase in cardiac output compensates for the decrease
in arterial oxygen content, so that the product of both, the
systemic oxygen delivery, remains unchanged at rest (38, 56).
With sojourns at altitude over several days, the resting cardiac
output normalizes through a decrease in stroke volume, which
is attributed to a hypoxia-induced reduction in plasma volume
and thus lower left ventricular end-diastolic volume (55).
Ventilation and heart rate, however, remain increased even
after acclimatization mediated by a sustained sympathetic re-
sponse driven by peripheral chemoreceptors sensitized by the
persistent hypoxemia (25, 26, 33). Under exercise, these adap-
tive mechanisms are additionally stressed, and performance is,
therefore, limited in the hypoxic environment at altitude. Sev-
eral studies have described a decreased maximal workload
(Wmax) and V˙ O2 associated with decreasing barometric pres-
sure and alveolar partial pressure of oxygen (PAO2) (79, 81).
Thus exercise at altitude is associated with a sustainably
elevated respiratory rate and consecutively increased minute
ventilation (V˙ E), even more upon acclimatization, which im-
proves the arterial O2 saturation from pulse oximetry (SpO2),
but is associated with a lower arterial PCO2 and higher venti-
latory equivalents for V˙ O2 and CO2 output (V˙ CO2) (V˙ E/V˙ O2 and
V˙ E/V˙ CO2, respectively), indicating ventilatory inefficiency
(Figs. 2 and 3) (26). During exercise at lowland, hyperpnea
allows healthy individuals to maintain a sufficiently high PAO2
that, together with flow-induced increased pulmonary vessel
recruitment and distention, ensures an adequate diffusion of
oxygen through the alveolar membrane, thereby preventing
exercise-induced hypoxemia through diffusion limitation, ex-
cept for highly trained athletes at very high work levels. At
altitude, the lower inspiratory PO2 and, consequently, the re-
duced arterial PO2 (PAO2) stimulate ventilation. At which level
of hypobaric hypoxia the associated increasingly high energy
cost of breathing eventually outweighs the hyperventilation-
induced increased oxygen availability, and thus limits exercise
performance, has not been exactly determined by experimental
evidence (7, 75, 80). Systemic availability of oxygen during
exercise at altitude is additionally hampered by limitation of
the alveolar-arterial oxygen diffusion due to an increased
cardiac output, which shortens the pulmonary capillary blood
transit time, thus precluding equilibration of the pulmonary
capillary PO2 with the reduced PAO2 (73). Thus, despite alveolar
microvascular recruitment by the enhanced cardiac output and
associated increased pulmonary capillary blood volume, the
oxygen loading onto hemoglobin at any given cardiac output is
reduced in hypoxia compared with normoxia, and the arterial
oxygen saturation, therefore, declines at a lower cardiac output.
The relative increase of the cardiac output during exercise at
altitude compared with sea level is not clear. Studies revealed
that, with acute exposure to hypoxia, the cardiac output was
increased at low workloads, along with a higher heart rate,
which was attributed to a combined inhibition of -adrenergic
and muscarinic receptors (57). At altitude, the maximal work
rate, the maximal V˙ O2 (V˙ O2max), heart rate, and cardiac output
were all decreased in comparison to sea level (12, 74), whereas
there was little change in the relationship between these vari-
ables (38, 49). Whether the reduced maximal cardiac output at
altitude is a cause or consequence of the decreased V˙ O2
remains uncertain (73).
Hypoxia induces pulmonary vasoconstriction, an adaption
that reduces ventilation-perfusion mismatch and optimizes the
lung diffusion and perfusion matching (8, 36). But exercise in
the hypoxic environment is associated with a deterioration of
ventilation-perfusion matching, which is only partly corrected
by hypoxic vasoconstriction (36). Thus it is thought that the
increase in pulmonary arterial pressure (PAP) induced by
hypoxic pulmonary vasoconstriction, together with the exer-
cise-induced increase in blood flow, contributes to gas ex-
change deterioration during exercise at altitude, although there
Pulmonary diffusion limitation
Pulmonary artery 
pressure  ↑
Plasma
volume ↓
PaO2 ↓
Chemoreceptors stimulation ↑
sympathetic activity ↑
Ventilation ↑  Heart Rate ↑ RV afterload ↑ 
Left ventricular 
preload (→) ↓
Stroke Volume 
(→)↓
Cardiac Output (↑) →
Hypoxia
PAO2 ↓
Oxygen delivery ↓
Fig. 1. Main adaptive mechanisms to exercise
under acute exposure to hypobaric hypoxia at
altitude or simulated hypoxia with hypoxic air
mixtures are shown. Feedback loops in be-
tween mechanisms are not shown, but play
additional roles.
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is a high interindividual variability in this response (34, 75).
Hypoxic pulmonary vasoconstriction, combined with a de-
creased pulmonary vascular distensibility, results in a steep
pressure/flow relationship during exercise, which, combined
with hypoxemia, contributes to limitations in performance at
altitude (50, 51). Studies showing that reduction of pulmonary
vascular resistance by phosphodiesterase inhibitors or endothe-
lin-receptor antagonists is associated with an increased V˙ O2
and exercise capacity at altitude and in normobaric hypoxia
support the notion that an increased right ventricular afterload
contributes to exercise limitation at altitude (13, 15, 19).
However, the interindividual contribution of this mechanism to
exercise limitation at altitude may vary considerably (34, 75).
As resting cardiac output returns to baseline within 1–2 wk
of acclimatization, even before the onset of polycythemia, an
increased cellular oxygen extraction has been postulated (38,
56), and this should be especially pronounced during exercise
to match the heightened oxygen demand of exercising muscles.
However, absolute oxygen extraction at rest and during peak
exercise were decreased in five subjects after 5–6 days at an
altitude of 4,559 m, with an unchanged oxygen extraction ratio
(i.e., an unchanged ratio of arterial-venous oxygen content to
Fig. 2. Data from maximal cycle exercise
in 32 mountaineers studied near sea level
(490 m) and after staying for 5– 6 and 11
days at an altitude of 5,533 m. Maximal
values for work rate (Wmax), oxygen up-
take (V˙ O2max), heart rate (HRmax), minute
ventilation (V˙ Emax), ventilatory equiva-
lents (V˙ E/V˙ O2 and V˙ E/V˙ CO2), pulse oxim-
etry (SpO2), and end-tidal PCO2 (PETCO2) are
shown. *P  0.05 vs. 490 m. †P  0.05
vs. day 5– 6 at 5,533 m. Data were derived
from a study by Latshang et al. (26).
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arterial oxygen content) (35). Responsible factors might in-
clude a limited tissue oxygen diffusion due to the reduced PaO2(72), a localized mismatch between oxygen demand and mi-
crocirculatory blood flow, an alteration in mitochondrial func-
tion, or a redistribution of blood flow between organs (27).
Further research is warranted to clarify changes in regional and
global oxygen extraction with altitude exposure.
Every physical activity starts with activation of the cerebral
motor cortex with consecutive temporal and spatial recruitment
of muscular units and ends with de-recruitment. Exercise is
centrally perceived by motor-sensory neuronal connections
that induce a sense of effort. When negative senses outweigh
the positive ones, exercise is volitionally terminated. Despite
the undoubted importance of these sensory aspects, they are
not widely appreciated due to their subjective nature (23).
However, which factors provide the input to the brain to stop
exercise? While these factors are likely to be the same at low
and high altitude, the hypoxic environment potentially alters
their relative importance or processing (41). At the end of
exercise at extreme altitude with a PaO2 of 26 Torr, subjects
were almost unconscious, but rated their breathlessness simi-
larly as high as their leg discomfort, despite no metabolic
fatigue (18). This observation may indicate that the exhausting
respiratory system limits the motor system via inhibition of
locomotor drive by the brain, whereas muscle metabolism does
not seem to be limiting (24, 53).
The studies discussed so far have provided insights into
some pulmonary, cardiovascular, muscular, and cerebral mech-
anisms of adaptation and limitation of exercise performance
under hypoxia (either hypobaric at altitude or normobaric at
sea level). However, the interpretation of the findings has to
account for weaknesses in the methods and design of these
mostly uncontrolled case studies performed in a small number
of mountaineers or athletes. In a systematic analysis of the
literature cited in PubMed (see APPENDIX A; search terms and
inclusion/exclusion criteria are detailed in Table A1), including
at least eight participants, we found five randomized-controlled
trials providing data on the effects of hypobaric hypoxia,
normobaric hypoxic gas mixtures, or altitude exposure on
exercise capacity quantified by Wmax or V˙ O2 (Tables A1 and
A2). Two of the studies were crossover trials in hypobaric
chambers (altitude equivalent of 3,800 m and up to 2,286 m)
(60, 71), where subjects were blinded to the chamber pressure,
a third was a field study in Indian soldiers (58), which were
randomized to exercise near sea level or after 4 wk of accli-
matization to 4,560 m, and two used normobaric hypoxia (9,
16). All studies showed a decreased exercise performance in
V˙ O2max under hypoxia compared with ambient air near sea
level. Furthermore, well-designed studies with modern meth-
odology are warranted to study the mechanisms of exercise
limitation in hypoxia.
EFFECT OF HYPEROXIA ON EXERCISE PERFORMANCE IN
HEALTHY INDIVIDUALS
Researchers have addressed the question of whether breath-
ing oxygen-enriched air (normobaric hyperoxia) would im-
prove exercise performance. Various studies with different FIO2
values and exercise modalities, mostly including a limited
number of trained athletes, revealed conflicting results, but
generally found an enhanced performance with hyperoxia. For
example, Wilson et al. (82) have shown that progressively
increasing FIO2 values were associated with dose-dependent
increases in running endurance of healthy subjects at 110% of
V˙ O2max. V˙ E was significantly decreased, whereas the maximal
heart rate was similar in different FIO2 conditions. In other
investigations, a decreased lactate accumulation under hyper-
oxia compared with normoxia was found at submaximal exer-
cise intensities (50–70% of peak V˙ O2), despite a prolonged
Fig. 3. Both hypoxia due to impaired pulmonary gas exchange in patients with pulmonary hypertension and environmental hypoxia in mountaineers similarly
induce ventilatory inefficiency. Plots of V˙ E/V˙ CO2 vs. PETCO2 during maximal cycle exercise in patients with PAH/CTEPH [left, data derived from Ulrich et al. (69)]
and healthy mountaineers [right, data derived from Latshang et al. (26)] are shown. Left: in PAH/CTEPH patients, lines start with values measured during ambient
air breathing (FIO2 0.21) near sea level and end in arrows representing values measured during breathing oxygen-enriched air (FIO2 0.5). Right: in mountaineers,
lines start with values measured at an altitude of 490 m and end in arrows measured on day 5–6 after ascent to an altitude of 5,533 m. Hyperoxia in patients
induced changes to the right along the line representing the rearranged alveolar gas equation (dashed shaded line), i.e., toward a greater ventilatory efficiency.
In mountaineers, exposure to hypoxia at high altitude induces changes in the opposite direction, i.e., toward a greater ventilatory inefficiency. Mechanisms of
acclimatization in mountaineers and physiological adaptations to long-term hypoxia that take place in PH patients are not represented.
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performance (29, 30). Further studies in a limited number of
mostly healthy young athletes found an unchanged or increased
maximal performance with higher FIO2 (22, 42, 45).
We recently studied the effect of breathing oxygen-enriched
air (FIO2 0.5) vs. ambient air (FIO2 0.21) in 32 healthy subjects
near sea level (460 m). They performed two exhaustive pro-
gressive ramp and two constant-load cycle cardiopulmonary
exercise tests (CPET), each under FIO2 0.5 and FIO2 0.21,
according to a randomized, sham-controlled crossover trial
(68). We found that breathing oxygen-enriched air increased
the maximal power output by 5.3% and endurance time in
constant-load CPET at 75% of the V˙ O2max by 52%. The higher
maximal work rate in progressive ramp exercise with hyper-
oxia compared with normoxia was associated with an im-
proved arterial, muscle and cerebral tissue oxygenation (CTO
measured by near-infrared spectroscopy) with a postponed
CTO decline. In addition, heart rate, V˙ E, and ventilatory
equivalents for V˙ CO2 and V˙ O2 at submaximal isoloads were
reduced (Fig. 4). Since the end-tidal PCO2 (PETCO2) was in-
creased in hyperoxia compared with normoxia, these findings
are consistent with a reduction in peripheral chemoreceptor
sensitivity by hyperoxia with relative reduction in alveolar
ventilation and a rise in the alveolar PCO2 (and, hence, PETCO2)(12). The higher CTO with postponed drop toward end-
exercise under hyperoxia may suggest a role of the brain in
exercise limitation (42, 66, 68). The higher V˙ O2 under
hyperoxia is not entirely understood, but may be related in
part to changes in metabolism, redistribution of blood flow,
differences in type and recruited muscle fibers, and in
metabolism of nonexercising tissues (47, 48, 68), Higher
blood lactate levels due to increased exercise under hyper-
oxia seem not to play a role (14).
In summary, oxygen-enriched air improves maximal work
rate and submaximal endurance time in healthy individuals
through a better arterial and cerebral oxygenation associated
with an enhanced ventilatory efficiency. In a systematic review
of the literature, we identified four randomized-controlled
trials, which included a least eight subjects and provided data
on the effect of hyperoxia vs. normoxia air on maximal
exercise performance in terms of workload or V˙ O2 (Table A2).
All revealed an increased workload of V˙ O2 under hyperoxia
(20, 42, 48, 68).
EFFECT OF HYPOBARIC HYPOXIA ON EXERCISE
PERFORMANCE IN PATIENTS WITH PH
Precapillary PH is a condition hemodynamically defined as
mean PAP  25 mmHg, along with a pulmonary arterial
wedge pressure  15 mmHg. In the absence of relevant lung
disease, the main forms are pulmonary arterial hypertension
(PAH), which occurs in idiopathic form or in association with
various diseases, or chronic thromboembolic PH (CTEPH)
(17). The main symptom is exertional dyspnea, which is
typically associated with oxygen desaturation, and leads to
reduced quality of life (59). In terms of lung function, the
Fig. 4. Effect of hyperoxia on exercise performance in 32 healthy subjects (68). Physiological variables during progressive ramp exercise are represented by open
circles for hyperoxia (FIO2 0.5) and by solid circles for normoxia (FIO2 0.21). Values are means  SE over successive deciles of the maximal workload (Wmax)
achieved under normoxia; i.e., the value of 5 (x-axis) represents the mean over the range of 1–10% of Wmax normoxia, etc. The last values represent means over
the final 15 s of maximal exercise in hyperoxia and normoxia. *P  0.05 for comparison of hyperoxia, FIO2 0.50, vs. normoxia, FIO2 0.21. QMTO, quadriceps
muscle tissue oxygenation.
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characteristic alteration in patients with PAH/CTEPH is a
reduction in diffusing capacity while lung volumes are gener-
ally within normal limits (69). Exposure to hypobaric hypoxia
at altitude or during air flights increases PAP through hypoxic
pulmonary vasoconstriction already in healthy individuals and,
presumably, even more in patients with PH due to their
impaired hemodynamics and gas exchange (10, 34, 67). Ac-
cording to questionnaire assessments on flight experience, the
percentage of PH patients perceiving symptoms during expo-
sure to a moderately hypoxic environment like commercial air
travel (with minimal cabin pressure equivalent to 2,437 m) is
mostly small (64). Thus among 179 air passengers with stable
PH, 46% of these were in New York Heart Association class II
or IV, 3% reported dyspnea, 3% peripheral edema, 2% exhaus-
tion, 1% each heart palpitations, chest pain, headache, wors-
ening of condition, or fear of flying, and a total of 4% required
a medical intervention; only 2% of the patients used supple-
mental oxygen during flights. In 34 PH patients flying at a
mean altitude equivalent of 1,968 m on average during 3.6 h,
there was a median drop in arterial oxygen saturation of 4.9%
(range 2–16%) (52). However, of the 13 patients (38%) who
reported symptoms during the flight, 5 (38%) also revealed
desaturation. Since no serious adverse events were reported in
this study, the clinical relevance of the findings remain elusive.
An adverse effect of altitude exposure and occurrence of
high-altitude pulmonary edema has been reported anecdotally
in patients with PH associated with malformations, absence or
occlusion of pulmonary arteries, or other rare PH forms (32).
Prospective data on patients with PH exposed to real altitude in
the mountains are lacking, so that most experts recommend
against altitude sojourns in PH or, if necessary, to use supple-
mental oxygen (31). In the absence of conclusive evidence,
current guidelines based on expert opinion recommend that PH
patients in functional class III and IV or with a PaO2  8 kPa
near sea level either avoid exposure to altitudes 1,500–2,000
m or use supplemental oxygen during altitude or air travel (17).
A systematic review of the literature cited in PubMed did not
reveal any randomized or prospective case series study evalu-
ating effects of exposure to hypoxia on exercise performance in
terms of maximal work rate or V˙ O2 in patients with PAH/
CTEPH. This lack of information may be related in part to
concerns of investigators of letting patients with advanced PH
perform strenuous exercise. Maximal exercise testing was
found safe under normoxic condition in PH patients (21, 61,
76, 78). In our own experience, a few minutes at rest in
normobaric hypoxia did not worsen hemodynamics in PH
patients with mild to moderate disease (A. Groth, unpub-
lished observations). However, the effect of hypoxia on
pulmonary hemodynamics under exercise has not been stud-
ied, and the lack of hemodynamic impairment with normo-
baric hypoxia at rest cannot exclude that certain patients
with severe disease might be at risk of right heart failure or
even sudden cardiac death when performing strenuous ex-
ercise. Robust evidence of the potential risk of exercise and
of exercise in hypoxia might help to counsel the increasing
number of PH patients who desire to travel to high-altitude
areas or to undergo air travel. Well-designed scientific
studies that appropriately address safety concerns are, there-
fore, urgently needed.
EFFECT OF HYPEROXIA ON EXERCISE PERFORMANCE IN
PATIENTS WITH PH
The exercise limitation and symptoms in patients with pre-
capillary PH have been attributed to their impaired hemody-
namics that lead to several pathophysiological consequences,
with a crucial finding being hyperventilation at rest and an
excessive ventilatory response to exercise, leading to high
ventilatory equivalents for V˙ CO2 (V˙ E/V˙ CO2) and V˙ O2 (V˙ E/V˙ CO2)
(62). The main underlying mechanisms are sympathetic over-
excitation and increased chemosensitivity with hyperventila-
tion-associated increased physiological dead space. Moreover,
there is an inadequate increase in cardiac output during exer-
cise, leading to a low mixed-venous and arterial oxygen satu-
ration and early lactic acidosis that raises ventilatory require-
ments even further due to excessive CO2 production (39, 65,
77). These mechanisms lead to arterial oxygen desaturation
during exercise as a cardinal feature of PH with, consequently,
reduced oxygen delivery to the muscles, the brain, and other
organs, resulting in impaired exercise performance (28, 37).
Thus it is comprehensible to hypothesize that breathing oxy-
gen-enriched air during physical activity in daily life or during
exercise training may improve performance in PH patients.
Although resting hemodynamics as well as arterial tissue
oxygenation and CTO improved in patients with PAH/CTEPH
while breathing oxygen during right heart catheterization, the
effect of hyperoxia on exercise performance had not been
adequately studied until recently (37). Therefore, current
guidelines recommending long-term oxygen therapy in PH
patients with resting PaO2  8 kPa or in case of symptomatic
benefit are not based on robust evidence (17). To address this
point, our laboratory performed a randomized, sham-controlled
trial demonstrating that nocturnal oxygen therapy in PAH/
CTEPH patients with nocturnal oxygen desaturation improves
not only sleep-disordered breathing, but also exercise capacity
(i.e., the 6-min walk distance) and symptoms during daytime
already after 1 wk (70). In recent further randomized trials in
patients with PAH/CTEPH, our laboratory has found that
breathing oxygen-enriched air (FIO2 0.50) compared with
breathing ambient air (FIO2 0.21) significantly enhanced max-
imal work rate in cycling ramp exercise tests and substantially
increased endurance in submaximal constant-load exercise
(69). These improvements were associated with a higher PaCO2
at end-exercise and a reduced ratio of V˙ E/V˙ CO2 (Fig. 3),
whereas the dead physiological space-to-tidal volume ratio
remained unchanged. This was consistent with a reduction in
excessive ventilatory drive by hyperoxia that reduced the
ventilatory requirement for V˙ CO2 through an increase in the
alveolar CO2 fraction and, consequently, the PETCO2 fraction.
Breathing oxygen-enriched air was associated with a higher
PaO2 and thus increased oxygen delivery to the tissues, result-
ing in a higher cerebral and quadriceps muscle tissue oxygen
saturation, indicating a better availability of oxygen in working
muscles and sensory and motoneurons, thus allowing higher
intensities and prolonged exercise with less dyspnea percep-
tion.
A systematic review of the literature cited in PubMed did not
identify any further randomized trials investigating the effect
of breathing oxygen-enriched air on exercise performance in
PAH/CTPEH, in addition to the ones described above (Table
A2) (69).
1662 Exercise in Hypoxia/Hyperoxia in Health and Pulmonary Hypertension • Ulrich S et al.
J Appl Physiol • doi:10.1152/japplphysiol.00186.2017 • www.jappl.org
Downloaded from www.physiology.org/journal/jappl by ${individualUser.givenNames} ${individualUser.surname} (130.060.047.136) on January 23, 2018.
Copyright © 2017 American Physiological Society. All rights reserved.
THERAPEUTIC IMPLICATIONS AND FUTURE RESEARCH
The reduced exercise capacity in healthy individuals ex-
posed to hypoxia can be increased by acclimatization (26),
presumably by supplemental oxygen and, according to ran-
domized-controlled trials, by pulmonary vasodilator drugs,
such as endothelin receptor antagonists or phosphodiesterase-5
inhibitors or (in subjects susceptible to high-altitude pulmonary
edema) by dexamethasone (19, 38, 40). Conversely, acetazol-
amide seems to reduce exercise capacity at altitude, despite a
higher SpO2 at rest, although these data are not conclusive (5).
Future studies are warranted to address the mode of actions of
drugs that modify pulmonary hemodynamics, gas exchange,
and control of breathing in healthy subjects. Moreover, a
clinically important research question is whether these drugs
would increase exercise capacity in the hypoxic environment
also in patients with PAH/CTEPH or other respiratory dis-
eases. Whether supplemental oxygen therapy in addition to
current drugs would improve the capacity to perform daily
activities or effectiveness of training in PAH/CTEPH patients
with exercise-induced hypoxemia remains to be determined in
future randomized trials (11). Further studies might investigate
other potential therapeutic options, such as inhaled steroids,
betamimetics, and other agents (6, 54).
CONCLUSIONS
Current evidence suggests that exposure to hypobaric or
normobaric hypoxia impairs exercise capacity in healthy sub-
jects by decreasing the inspiratory PO2, PAO2, and PAO2, thereby
reducing the availability of oxygen in working muscles, in the
brain, and in other tissues. In patients with PH, the exercise
performance is impaired already in normoxia and, presumably,
even more so in hypoxic conditions. The main mechanisms of
exercise limitation in PH are comparable to those in healthy
individuals, but are even more pronounced at corresponding
exercise levels.
Recent randomized trials indicate that normobaric hyperoxia
achieved by breathing oxygen-enriched air increases exercise
performance in healthy subjects and even more in PH patients.
These improvements are mediated by a reduction of the ven-
tilatory drive, allowing for a better ventilatory efficiency, and
by an increased availability of oxygen in the working muscles
and in the brain, leading to less dyspnea and a greater exercise
tolerance. Future studies should address whether these acute
improvements under hyperoxia would translate into an in-
creased training effect or better daily performance of PH
patients who are treated with supplemental oxygen at long
term.
APPENDIX A: SYSTEMATIC SEARCH OF THE LITERATURE
A systematic search on the medical database PubMed (https://
www.ncbi.nlm.nih.gov/pubmed/) was conducted from inception to
January 31, 2017. The search strategy and the number of returned
articles are listed below in Tables A1 and A2. Titles and abstracts of
the returned articles were reviewed for the following inclusion criteria
to select high-quality research: randomization to exercise under acute
hypoxia or acute hyperoxia, a sample size of at least eight healthy
subjects, and quantitative data on maximal exercise capacity and/or
V˙ O2.
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